A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)

by | May 22, 2026 | Clinical Trials | 0 comments

​ Conditions: Pulmonary Arterial Hypertension

Interventions: Biological: Sotatercept; Drug: Background PAH Therapy

Sponsors: Merck Sharp & Dohme LLC

Not yet recruiting Conditions: Pulmonary Arterial Hypertension
Interventions: Biological: Sotatercept; Drug: Background PAH Therapy
Sponsors: Merck Sharp & Dohme LLC
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *